Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+

  Stem Cell Research

  Free Subscription

Articles published in Leuk Res

Retrieve available abstracts of 34 articles:
HTML format
Text format

Single Articles

    November 2019
  1. MASSE A, Roulin L, Pasanisi J, Penneroux J, et al
    BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.
    Leuk Res. 2019;87:106269.
    PubMed     Text format     Abstract available

  2. GENG C, Liu X, Chen M, Yang C, et al
    Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
    Leuk Res. 2019;88:106266.
    PubMed     Text format     Abstract available

    October 2019
  3. MIYAMURA T, Kudo K, Tabuchi K, Ishida H, et al
    Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Leuk Res. 2019;87:106263.
    PubMed     Text format     Abstract available

    September 2019
  4. NAKAMURA R, Gendzekhadze K, Palmer J, Tsai NC, et al
    Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
    Leuk Res. 2019;87:106230.
    PubMed     Text format     Abstract available

    August 2019
  5. ANDRITSOS LA, Huang Y, Abraham I, Huff K, et al
    Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.
    Leuk Res. 2019;85:106215.
    PubMed     Text format     Abstract available

    July 2019
  6. FALCONI G, Fabiani E, Criscuolo M, Fianchi L, et al
    Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
    Leuk Res. 2019;84:106191.
    PubMed     Text format     Abstract available

  7. HUANG SJ, Chan J, Bruyere H, Allan LL, et al
    Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Leuk Res. 2019;84:106193.
    PubMed     Text format     Abstract available

    June 2019
  8. KINSELLA FAM, Inman CF, Gudger A, Chan YT, et al
    Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.
    Leuk Res. 2019;83:106173.
    PubMed     Text format     Abstract available

  9. MODI D, Surapaneni M, Kim S, Ayash L, et al
    Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.
    Leuk Res. 2019;83:106171.
    PubMed     Text format    

  10. FANG J, Zhang R, Wang H, Hong M, et al
    Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [L
    Leuk Res. 2019;81:107.
    PubMed     Text format    

    May 2019
  11. JANN JC, Nolte F, Mossner M, Flach J, et al
    Comparative analysis of clonal hematopoiesis of multipotent stem cells in healthy elderly in blood and bone marrow.
    Leuk Res. 2019;82:15-18.
    PubMed     Text format    

    April 2019
  12. MOSHAVER B, Wouters RF, Kelder A, Ossenkoppele GJ, et al
    Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
    Leuk Res. 2019;81:27-34.
    PubMed     Text format     Abstract available

    January 2019
  13. DANN EJ
    Should patient age be an obstacle for high-dose therapy and stem cell rescue?
    Leuk Res. 2019;78:34-35.
    PubMed     Text format    

  14. LEMIEUX C, Ahmad I, Bambace NM, Bernard L, et al
    Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
    Leuk Res. 2019 Jan 6. pii: S0145-2126(19)30002.
    PubMed     Text format     Abstract available

    November 2018
  15. ITONAGA H, Ota S, Ikeda T, Taji H, et al
    Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
    Leuk Res. 2018;75:50-57.
    PubMed     Text format     Abstract available

    September 2018
  16. NAKAMURA M, Wu L, Griffin JD, Kojika S, et al
    Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors.
    Leuk Res. 2018;72:34-44.
    PubMed     Text format     Abstract available

    August 2018
  17. LI D, Lin TL, Lipe B, Hopkins RA, et al
    A novel extracellular matrix-based leukemia model supports leukemia cells with stem cell-like characteristics.
    Leuk Res. 2018;72:105-112.
    PubMed     Text format     Abstract available

  18. LEI H, Yang L, Zhou L, Tong Y, et al
    Targeting acute myeloid leukemia CD34(+) stem/progenitor cells with small molecule inhibitor MK-8776.
    Leuk Res. 2018;72:71-73.
    PubMed     Text format    

  19. GURNARI C, Latagliata R, Buccisano F, Piciocchi A, et al
    Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes.
    Leuk Res. 2018;71:89-91.
    PubMed     Text format    

    July 2018
  20. RIVERA-FRANCO MM, Leon-Rodriguez E, Lastra-German IK, Mendoza-Farias AA, et al
    Association of recipient and donor hypercholesterolemia prior allogeneic stem cell transplantation and graft-versus-host disease.
    Leuk Res. 2018;72:74-78.
    PubMed     Text format     Abstract available

  21. OGATA K, Sei K, Saft L, Kawahara N, et al
    Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Leuk Res. 2018;71:75-81.
    PubMed     Text format     Abstract available

    June 2018
  22. LIU C, Wei H, Yao X, Liu B, et al
    Retraction notice to "Arsenic Trioxide Inhibits Proliferation and Induced apoptosis of Leukemia Stem Cells with Drug Resistance " [LR 69 (2018) 66-71].
    Leuk Res. 2018;69:103.
    PubMed     Text format    

    May 2018
  23. IOVINO L, Mazziotta F, Carulli G, Guerrini F, et al
    High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation.
    Leuk Res. 2018;70:20-24.
    PubMed     Text format     Abstract available

    April 2018
  24. TANG L, Wang N, Xing C, Zhuang Q, et al
    Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning.
    Leuk Res. 2018;69:60-65.
    PubMed     Text format     Abstract available

  25. PARK H, Lee YJ, Shin SJ, Lee J, et al
    Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population.
    Leuk Res. 2018;69:31-38.
    PubMed     Text format     Abstract available

  26. LIU P, Jiang H, Che M, Fu R, et al
    Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes.
    Leuk Res. 2018;67:12-16.
    PubMed     Text format     Abstract available

    March 2018
  27. LIU C, Wei H, Yao X, Liu B, et al
    Arsenic trioxide inhibits proliferation and induced apoptosis of leukemia stem cells with drug resistance.
    Leuk Res. 2018;69:66-71.
    PubMed     Text format     Abstract available

    January 2018
  28. CUI P, Zhang Y, Cui M, Li Z, et al
    Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
    Leuk Res. 2018;65:49-54.
    PubMed     Text format     Abstract available

    November 2017
  29. LEON-RODRIGUEZ E, Rivera-Franco MM, Gomez-Martin D, Romo-Tena J, et al
    Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.
    Leuk Res. 2017;63:47-52.
    PubMed     Text format     Abstract available

    October 2017
  30. OZDOGAN H, Gur Dedeoglu B, Oztemur Islakoglu Y, Aydos A, et al
    DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Leuk Res. 2017;63:62-71.
    PubMed     Text format     Abstract available

  31. CANDONI A, De Marchi F, Zannier ME, Lazzarotto D, et al
    High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Leuk Res. 2017;63:22-27.
    PubMed     Text format     Abstract available

    September 2017
  32. AZUMA K, Umezu T, Imanishi S, Asano M, et al
    Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Leuk Res. 2017;62:23-28.
    PubMed     Text format     Abstract available

  33. OU R, Huang J, Shen H, Liu Z, et al
    Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
    Leuk Res. 2017;62:40-50.
    PubMed     Text format     Abstract available

    July 2017
  34. AGGOUNE D, Sorel N, Bonnet ML, Goujon JM, et al
    Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).
    Leuk Res. 2017;60:94-102.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.